Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Related Citations for PubMed (Select 24890445)

1.

Prognostic value of pretreatment 18 F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.

Kikuchi M, Koyasu S, Shinohara S, Usami Y, Imai Y, Hino M, Itoh K, Tona R, Kanazawa Y, Kishimoto I, Harada H, Naito Y.

Head Neck. 2014 Jun 2. doi: 10.1002/hed.23784. [Epub ahead of print]

PMID:
24890445
2.

Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.

Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K, Hayashida K, Itoh K, Togashi K.

AJR Am J Roentgenol. 2014 Apr;202(4):851-8. doi: 10.2214/AJR.13.11013.

PMID:
24660716
3.

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.

Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL.

J Radiat Oncol. 2013 Mar;2(1):27-34.

4.

Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.

Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC.

J Nucl Med. 2013 Oct;54(10):1703-9. doi: 10.2967/jnumed.112.119289. Epub 2013 Sep 16.

5.

18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H.

J Nucl Med. 2012 Oct;53(10):1506-13. doi: 10.2967/jnumed.111.101402. Epub 2012 Aug 14.

6.

Interaction of quantitative 18F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJ, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R.

Head Neck. 2014 Oct 29. doi: 10.1002/hed.23920. [Epub ahead of print]

PMID:
25352335
7.

Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.

Yoo J, Choi JY, Moon SH, Bae DS, Park SB, Choe YS, Lee KH, Kim BT.

Int J Gynecol Cancer. 2012 Sep;22(7):1226-33. doi: 10.1097/IGC.0b013e318260a905.

PMID:
22810970
8.

Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC.

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1673-84. doi: 10.1007/s00259-012-2186-9. Epub 2012 Aug 2.

PMID:
22854984
9.

Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.

Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

J Nucl Med. 2013 Jul;54(7):1032-8. doi: 10.2967/jnumed.112.116053. Epub 2013 May 13.

10.

Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.

Choi KH, Yoo IeR, Han EJ, Kim YS, Kim GW, Na SJ, Sun DI, Jung SL, Jung CK, Kim MS, Lee SY, Kim SH.

Nucl Med Mol Imaging. 2011 Mar;45(1):43-51. doi: 10.1007/s13139-010-0063-7. Epub 2010 Nov 16.

11.

Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.

Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC, Park K, Lee KH, Kim BT.

Head Neck. 2013 Jan;35(1):15-22. doi: 10.1002/hed.22904. Epub 2012 Feb 6.

PMID:
22307893
12.

Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.

Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.

Ann Surg. 2013 Feb;257(2):364-70. doi: 10.1097/SLA.0b013e318262a6ec.

PMID:
22968069
13.

18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.

Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM.

J Nucl Med. 2012 May;53(5):709-15. doi: 10.2967/jnumed.111.099531. Epub 2012 Apr 9.

14.

Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.

Chan JY, Sanguineti G, Richmon JD, Marur S, Gourin CG, Koch W, Chung CH, Quon H, Bishop JA, Aygun N, Agrawal N.

Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1040-6. doi: 10.1001/jamaoto.2013.607.

15.

Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.

Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53. doi: 10.1016/j.ijrobp.2010.11.050. Epub 2011 Jan 27.

PMID:
21277108
16.

Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.

Yoo J, Choi JY, Lee KT, Heo JS, Park SB, Moon SH, Choe YS, Lee KH, Kim BT.

Nucl Med Mol Imaging. 2012 Sep;46(3):201-6. doi: 10.1007/s13139-012-0147-7. Epub 2012 Jun 19.

17.

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node.

Jwa E, Lee SW, Kim JS, Park JH, Kim SS, Kim YS, Yoon SM, Song SY, Kim JH, Choi EK, Ahn SD.

Radiat Oncol J. 2012 Dec;30(4):173-81. doi: 10.3857/roj.2012.30.4.173. Epub 2012 Dec 31.

18.

Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.

Maharjan S, Sharma P, Patel CD, Sharma DN, Dhull VS, Jain SK, Thulkar S, Malhotra A, Kumar R.

Nucl Med Commun. 2013 Aug;34(8):741-8. doi: 10.1097/MNM.0b013e3283622f0d.

PMID:
23676840
19.

Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.

Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW, Lee J, Ahn BC.

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1321-9. doi: 10.1007/s00259-013-2443-6. Epub 2013 May 15.

PMID:
23674211
20.

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, Lee JY, Lee KH, Kim BT.

Ann Surg Oncol. 2010 Jan;17(1):115-22. doi: 10.1245/s10434-009-0719-7. Epub 2009 Oct 14.

PMID:
19826877
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk